[Modern diabetes management. DPP-4 inhibitors have been established as progress (interview by Christine Vetter)].
Gallwitz
Baptist
B
Medizinischen Klinik IV an der Eberhard-Karls-Universität Tübingen.
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D018819:Dipeptidyl Peptidase 4; D054873:Dipeptidyl-Peptidase IV Inhibitors; D004359:Drug Therapy, Combination; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*
D054873:Dipeptidyl-Peptidase IV Inhibitors; D007004:Hypoglycemic Agents; C042807:DPP4 protein, human; D018819:Dipeptidyl Peptidase 4